International Normalized Ratio

International Normalized Ratio, or INR, is a biomarker related to coagulation—the process involved in blood clotting. It is used to place information about coagulation in context.

International Normalized Ratio is tested using a plasma sample obtained from blood. The sample is processed so the result can be reported as a ratio and compared with the relevant reference and optimal ranges.

Fasting is not required for this test, so it can generally be arranged without fasting beforehand. When reviewing the result, interpretation should take account of the ranges shown for the test and the clinical context in which it was ordered. Related testing may include Pt and Vitamin K1, depending on the assessment being carried out.

A reference range is the interval used to assess whether a result falls within the expected range for that test. An optimal range is narrower: a result can be inside the reference range without also being inside the tighter optimal range. These ranges should be read as interpretive guides rather than diagnoses.

Laboratories may use their own reference ranges and units, so a number is meaningful only when compared with the range printed on the same report. The sample type and testing context also form part of how a result is interpreted.

A single value does not establish a diagnosis or explain why a result is higher or lower than expected. If a result is outside the report’s reference range, its significance should be discussed with a clinician, who can consider the result alongside symptoms, medical history, and other findings.

Direct measurements of International Normalized Ratio found different results across interventions. L-Carnitine decreased the marker in the trial that assessed it. Flaxseed Oil, Chamomile, and Ginger left INR unchanged in their respective studies, so these results do not indicate a consistent movement in either direction across all interventions.

The studies retested INR after 1 to 7 weeks, describing relatively short-term changes rather than longer-term effects. Because INR has an optimal range, a movement in either direction may matter depending on the starting value and clinical context. These findings come from direct measurements of the marker, but they should not be treated as a reason to start, stop, or adjust an intervention. Anyone with a medical condition involving INR should review potential changes with a clinician.